Liya Ma

642 total citations
39 papers, 305 citations indexed

About

Liya Ma is a scholar working on Hematology, Molecular Biology and Genetics. According to data from OpenAlex, Liya Ma has authored 39 papers receiving a total of 305 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Hematology, 10 papers in Molecular Biology and 10 papers in Genetics. Recurrent topics in Liya Ma's work include Acute Myeloid Leukemia Research (24 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (8 papers) and Histone Deacetylase Inhibitors Research (5 papers). Liya Ma is often cited by papers focused on Acute Myeloid Leukemia Research (24 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (8 papers) and Histone Deacetylase Inhibitors Research (5 papers). Liya Ma collaborates with scholars based in China, Hong Kong and United States. Liya Ma's co-authors include Xinping Zhou, Hongyan Tong, Yanling Ren, Chen Mei, Jie Jin, Yingwan Luo, Li Ye, Weilai Xu, Gaixiang Xu and Cherry Y. Leung and has published in prestigious journals such as Blood, Scientific Reports and Science Advances.

In The Last Decade

Liya Ma

35 papers receiving 305 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Liya Ma China 11 121 107 93 65 53 39 305
Benjamin Thiele Germany 10 101 0.8× 85 0.8× 95 1.0× 76 1.2× 55 1.0× 20 315
Pascale Willem South Africa 11 86 0.7× 69 0.6× 171 1.8× 60 0.9× 145 2.7× 28 317
Vittorio Del Fabro Italy 9 134 1.1× 100 0.9× 93 1.0× 74 1.1× 23 0.4× 32 263
Bita Fakhri United States 11 118 1.0× 69 0.6× 128 1.4× 57 0.9× 63 1.2× 37 269
Simon Hallam United Kingdom 9 164 1.4× 179 1.7× 161 1.7× 52 0.8× 56 1.1× 23 400
Christin B. DeStefano United States 10 147 1.2× 99 0.9× 138 1.5× 34 0.5× 50 0.9× 30 292
Thilo Zander Switzerland 10 61 0.5× 95 0.9× 143 1.5× 58 0.9× 70 1.3× 25 308
Gerald Gehbauer Germany 5 204 1.7× 176 1.6× 102 1.1× 32 0.5× 33 0.6× 5 330
George Mo United States 8 50 0.4× 89 0.8× 165 1.8× 66 1.0× 26 0.5× 19 345
Mayur Narkhede United States 8 143 1.2× 63 0.6× 131 1.4× 116 1.8× 124 2.3× 40 320

Countries citing papers authored by Liya Ma

Since Specialization
Citations

This map shows the geographic impact of Liya Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Liya Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Liya Ma more than expected).

Fields of papers citing papers by Liya Ma

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Liya Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Liya Ma. The network helps show where Liya Ma may publish in the future.

Co-authorship network of co-authors of Liya Ma

This figure shows the co-authorship network connecting the top 25 collaborators of Liya Ma. A scholar is included among the top collaborators of Liya Ma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Liya Ma. Liya Ma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhou, De, Xianbo Huang, Lixia Zhu, et al.. (2025). Ruxolitinib combined with dexamethasone for adult patients with newly diagnosed hemophagocytic lymphohistiocytosis in China. Blood. 146(3). 318–327. 2 indexed citations
2.
Yin, Xuejiao, Yi Liu, Jianping Ge, et al.. (2025). IFN-γ promotes the progression of iMCD by activating inflammatory monocytes. Blood. 146(1). 76–88.
3.
Jiang, Xiaohui, et al.. (2025). Global trends in cataract burden: a 30-year epidemiological analysis and prediction of 2050 from the Global Burden of Disease 2021 study. British Journal of Ophthalmology. 110(2). 139–147. 1 indexed citations
4.
Li, Yanjie, et al.. (2025). β-Glucan modulates trained immunity to inhibit osteoclast differentiation via NOD2/RIPK2 signaling pathway. International Immunopharmacology. 159. 114886–114886.
5.
You, Liangshun, Yi Liu, Wenyuan Mai, et al.. (2024). Venetoclax plus cytarabine and azacitidine in relapsed/refractory AML: An open-label, single-arm, phase 2 study. European Journal of Cancer. 202. 113979–113979. 3 indexed citations
6.
Zhang, Yudi, Jiejing Qian, Xinping Zhou, et al.. (2024). The m6A methyltransferase METTL14 promotes cell proliferation via SETBP1-mediated activation of PI3K-AKT signaling pathway in myelodysplastic neoplasms. Leukemia. 38(10). 2246–2258. 5 indexed citations
7.
8.
Liu, Xudong, Haiyi Li, Yue Zhao, et al.. (2022). Reproducibility and relative validity of a food frequency questionnaire for a diet-related study in a rural Chinese population. Nutrition Journal. 21(1). 3–3. 11 indexed citations
9.
Ye, Li, Liya Ma, Yanling Ren, et al.. (2022). Predictive values of mutational variant allele frequency in overall survival and leukemic progression of myelodysplastic syndromes. Journal of Cancer Research and Clinical Oncology. 148(4). 845–856. 6 indexed citations
10.
11.
Ren, Yanling, Wei Lang, Chen Mei, et al.. (2022). Co‐mutation landscape and clinical significance of RAS pathway related gene mutations in patients with myelodysplastic syndrome. Hematological Oncology. 41(1). 159–166. 7 indexed citations
12.
Zhao, Lei, Yuanyuan Zhang, Yi Xiao, et al.. (2020). CAR T-Cell Therapy Is Effective but Not Long-Lasting in B-Cell Lymphoma of the Brain. Frontiers in Oncology. 10. 1306–1306. 32 indexed citations
13.
14.
Luo, Yingwan, Lu Wang, Liya Ma, et al.. (2019). Mutation status and burden can improve prognostic prediction of patients with lower‐risk myelodysplastic syndromes. Cancer Science. 111(2). 580–591. 29 indexed citations
15.
Ye, Li, Yanling Ren, Xinping Zhou, et al.. (2019). Decitabine improves overall survival in myelodysplastic syndromes-RAEB patients aged ≥60 years and has lower toxicities: Comparison with low-dose chemotherapy. Blood Cells Molecules and Diseases. 77. 88–94. 4 indexed citations
16.
Lin, Peipei, Yingwan Luo, Dominic Maggio, et al.. (2018). Isocitrate dehydrogenase 2 mutations correlate with leukemic transformation and are predicted by 2-hydroxyglutarate in myelodysplastic syndromes. Journal of Cancer Research and Clinical Oncology. 144(6). 1037–1047. 17 indexed citations
17.
Ma, Liya, et al.. (2016). Successful treatment of Candida tropicalis osteomyelitis with Micafungin in a leukemia patient. IDCases. 6. 109–111. 5 indexed citations
18.
19.
Hu, Xuemei, Liya Ma, Jinhua Zhang, et al.. (2014). Study of CT pulmonary angiography technique in pulmonary embolism-low dose and low concentration. Zhonghua fangshexian yixue zazhi. 48(10). 811–815.
20.
Ma, Liya, Gaixiang Xu, Anna Sotnikova, et al.. (2007). Loss of expression of LyGDI (ARHGDIB), a rho GDP‐dissociation inhibitor, in Hodgkin lymphoma*. British Journal of Haematology. 139(2). 217–223. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Benjamin Thiele Breakdown of academic impact, for papers by Pascale Willem Breakdown of academic impact, for papers by Vittorio Del Fabro Breakdown of academic impact, for papers by Bita Fakhri Breakdown of academic impact, for papers by Simon Hallam Breakdown of academic impact, for papers by Christin B. DeStefano Breakdown of academic impact, for papers by Thilo Zander Breakdown of academic impact, for papers by Gerald Gehbauer Breakdown of academic impact, for papers by George Mo Breakdown of academic impact, for papers by Mayur Narkhede
Rankless by CCL
2026